Financial Market

OTC Markets Group (OTCMKTS:OTCM) Upgraded by Zacks Investment Research to Hold

OTC Markets Group (OTCMKTS:OTCMGet Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Saturday, Zacks.com reports.

According to Zacks, “OTC Markets Group Inc. is an open, transparent, and connected marketplace platform providing financial information and technology services to broker-dealers, issuers of OTC traded securities, and market data consumers. Its OTC Link (registered) ATS directly links a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. Its OTCQuote.com, helps in viewing real-time OTC market quote and trade data; OTC FIX for quote submission, trading, and routing of execution reports. The company also provides data products comprising Real-Time+, a multicast data product suite that allows market data terminal providers and financial website operators to give the general public a view into the real-time pricing of 10,000 OTC securities. Other products include End-of-Day data file, Company data file, Quote History, research/data mining service. The company was formerly known as Pink OTC Markets Inc. and is headquartered in New York, New York. “

Shares of OTC Markets Group stock opened at $56.80 on Friday. OTC Markets Group has a 12 month low of $41.25 and a 12 month high of $66.94. The business has a fifty day simple moving average of $58.38 and a 200 day simple moving average of $58.85. The stock has a market cap of $673.42 million, a PE ratio of 22.10, a price-to-earnings-growth ratio of 2.55 and a beta of 0.70.

(Ad)

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

OTC Markets Group (OTCMKTS:OTCMGet Rating) last announced its quarterly earnings data on Wednesday, March 9th. The financial services provider reported $0.74 EPS for the quarter, topping analysts’ consensus estimates of $0.55 by $0.19. The company had revenue of $26.19 million for the quarter, compared to analyst estimates of $23.56 million. As a group, research analysts predict that OTC Markets Group will post 2.4 earnings per share for the current fiscal year.

OTC Markets Group Company Profile (Get Rating)

OTC Markets Group Inc engages in the financial market business in the United States and internationally. It offers OTC Link Alternative Trading System, an interdealer quotation and trade messaging system; OTC Dealer, a real-time, front-end application that provides consolidated quotation, trading, and information system to attract and access market liquidity; OTC FIX, which uses the industry standard FIX protocol for quote submission, trading, and routing of execution reports; and OTC Link Electronic Communication Networks (ECN) and OTC Link National Quotation Bureau (NQB) that acts as the executing party on an agency basis in relation to transactions executed on platforms.

Featured Stories

Get a free copy of the Zacks research report on OTC Markets Group (OTCM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in OTC Markets Group right now?

Before you consider OTC Markets Group, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and OTC Markets Group wasn’t on the list.

While OTC Markets Group currently has a “N/A” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 

Source link

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button
SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.